CHO AESOP has a total of 13 patent applications. Its first patent ever was published in 2004. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are ARIAD PHARMA INC, KOTOBUKI PHARMACEUTICAL CO LTD and ROBL JEFFREY A.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Australia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Special acyclic compounds | |
#5 | Peptides | |
#6 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Cho Aesop | 13 |
#2 | Kim Choung U | 8 |
#3 | Clarke Michael O'Neil Hanrahan | 5 |
#4 | Pyun Hyung-Jung | 4 |
#5 | Sheng Xiaoning C | 4 |
#6 | Kirschberg Thorsten A | 4 |
#7 | Chong Lee S | 4 |
#8 | Link John O | 3 |
#9 | Wu Qiaoyin | 3 |
#10 | Fardis Maria | 3 |
Publication | Filing date | Title |
---|---|---|
US2012009147A1 | 2'-fluoro substituted carba-nucleoside analogs for antiviral treatment | |
AU2004233992A1 | Immunomodulator phosphonate conjugates |